Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration

Pediatr Nephrol. 2007 Jul;22(7):1062-5. doi: 10.1007/s00467-007-0436-z. Epub 2007 Feb 3.

Abstract

An infant with a suspected inborn metabolism error was treated with a metabolic cocktail of intravenous sodium phenylacetate (NaPh) and sodium benzoate (NaBz) for hyperammonemia. Sequential hemodialysis (HD) then hemofiltration (HF) was performed due to hyperammonemia. Dialytic and convective clearance (K; ml/min) of ammonia, NaPh, and NaBz was measured. The K of ammonia was 57 and 37 for HD and HF, respectively. The K of NaBz was 37 and 12 for HD and HF, respectively. The K of NaPh was 38 and 14 ml/min for HD and HF, respectively. Despite high clearance of both NaPh and NaBz by HD and HF, the hyperammonemia was corrected.

Publication types

  • Case Reports

MeSH terms

  • Ammonia / blood
  • Ammonia / pharmacokinetics
  • Hemofiltration*
  • Humans
  • Hyperammonemia / etiology*
  • Hyperammonemia / therapy*
  • Infant, Newborn
  • Phenylacetates / adverse effects
  • Phenylacetates / blood
  • Phenylacetates / pharmacokinetics*
  • Phenylacetates / therapeutic use
  • Renal Dialysis*
  • Sodium Benzoate / adverse effects
  • Sodium Benzoate / blood
  • Sodium Benzoate / pharmacokinetics*
  • Sodium Benzoate / therapeutic use

Substances

  • Phenylacetates
  • Ammonia
  • phenylacetic acid
  • Sodium Benzoate